Design and Validation of an Automated Process for the Expansion of Peripheral Blood‐Derived CD34(+) Cells for Clinical Use After Myocardial Infarction

We previously demonstrated that intracardiac delivery of autologous peripheral blood‐derived CD34(+) stem cells (SCs), mobilized by granulocyte‐colony stimulating factor (G‐CSF) and collected by leukapheresis after myocardial infarction, structurally and functionally repaired the damaged myocardial...

Descripción completa

Detalles Bibliográficos
Autores principales: Saucourt, Claire, Vogt, Sandrine, Merlin, Amandine, Valat, Christophe, Criquet, Anthony, Harmand, Laurence, Birebent, Brigitte, Rouard, Hélène, Himmelspach, Christian, Jeandidier, Éric, Chartois‐Leauté, Anne‐Gaële, Derenne, Sophie, Koehl, Laurence, Salem, Joe‐Elie, Hulot, Jean‐Sébastien, Tancredi, Céline, Aries, Anne, Judé, Sébastien, Martel, Eric, Richard, Serge, Douay, Luc, Hénon, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Manufacturing for Regenerative Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646685/
https://www.ncbi.nlm.nih.gov/pubmed/31037857
http://dx.doi.org/10.1002/sctm.17-0277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646685/
https://www.ncbi.nlm.nih.gov/pubmed/31037857
http://dx.doi.org/10.1002/sctm.17-0277

Ejemplares similares